反応式
[F:1][C:2]([F:15])([F:14])[C:3]1[CH:12]=[C:11]2[C:6]([CH2:7][CH2:8][NH:9][C:10]2=[O:13])=[CH:5][CH:4]=1.Br[C:17]1[CH:18]=[N:19][CH:20]=[CH:21][C:22]=1[CH2:23][N:24]1[CH2:28][CH2:27][CH2:26][CH2:25]1.P([O-])([O-])([O-])=O.[K+].[K+].[K+]>[Cu](I)I.O1CCOCC1>[N:24]1([CH2:23][C:22]2[CH:17]=[CH:18][N:19]=[CH:20][C:21]=2[N:9]2[CH2:8][CH2:7][C:6]3[C:11](=[CH:12][C:3]([C:2]([F:1])([F:14])[F:15])=[CH:4][CH:5]=3)[C:10]2=[O:13])[CH2:25][CH2:26][CH2:27][CH2:28]1参加物
6
実験手順
Using analogous conditions as described for the preparation of Example 1A above, 7-(trifluoromethyl)-3,4-dihydroisoquinolin-1(2H)-one (I-4-d: 100 mg, 0.465 mmol) was reacted with 3-bromo-4-(pyrrolidin-1-ylmethyl)pyridine (I-52a: 140 mg, 0.558 mmol), 1,4-dioxane (10 mL), copper iodide (8.8 mg, 0.0465 mmol), trans-N,N′-dimethyl-cyclohexyl-1, 2-diamine (19.8 mg, 0.139 mmol) and potassium phosphate (295 mg, 1.395 mmol) to afford the crude product. Purification by column chromatography on silica gel (12% methanol in CHCl3), followed by preparative HPLC afforded 7 mg of the product (4.02% yield).
後処理
- customas described for the preparation of Example 1A above
- customto afford the crude product
- customPurification by column chromatography on silica gel (12% methanol in CHCl3)
出典と根拠
- ORDレコード
- ord-36b4ec8dc36145b4a61e70ec2e08e8b4
- 出典データセット
- uspto-grants-2015_02
- 特許番号
- US08946260B2
関連ノート
読み込み中…